reviewThe LancetJan 1, 2007Closed access

Drug treatments for obesity: orlistat, sibutramine, and rimonabant

RPRaj PadwalSRSumit R. Majumdar

University of Alberta Hospital · Alberta Hospital Edmonton

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

748
total citations
FWCI
61.17
Percentile
100%
References
76
Citations per year

Authors

2

Topics & keywords

Topics
Keywords
  • Orlistat
  • Sibutramine
  • Medicine
  • Weight loss
  • Rimonabant
  • Internal medicine
  • Obesity
  • Adverse effect
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.